Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Mofenson

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 4, 2017
Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041B Zeldow, S Kim, G McSherry, et al.
Infectious Diseases in Obstetrics and Gynecology|November 7, 2009
Treatment interruption after pregnancy: effects on disease progression and laboratory findingsD H Watts, M Lu, B Thompson, et al.
Pediatrics|May 1, 1999
Combination therapy with stavudine (d4T) plus didanosine (ddI) in children with human immunodeficiency virus infection. The Pediatric AIDS Clinical Trials Group 327 TeamM W Kline, R B Van Dyke, J C Lindsey, et al.
Pediatrics|February 2, 1999
Planning for children whose parents are dying of HIV/AIDS. American Academy of Pediatrics. Committee on Pediatric AIDS, 1998-1999C Wilfert, J E Aronson, D T Beck, et al.
AIDS (London, England)|October 16, 2001
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)S H Eshleman, M Mracna, L A Guay, et al.
The Pediatric Infectious Disease Journal|July 6, 2000
Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study GroupJ S Read, K C Rich, J J Korelitz, et al.
AIDS (London, England)|March 1, 1996
Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmissionE M Rodriguez, L M Mofenson, B H Chang, et al.
The Journal of Infectious Diseases|August 1, 1997
Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. Women and Infants Transmission StudyR C Hershow, K A Riester, J Lew, et al.
The New England Journal of Medicine|August 5, 1999
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 TeamL M Mofenson, J S Lambert, E R Stiehm, et al.
The Journal of Infectious Diseases|June 2, 1998
Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission StudyD L Thomas, S A Villano, K A Riester, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 4, 2017
Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041B Zeldow, S Kim, G McSherry, et al.
Infectious Diseases in Obstetrics and Gynecology|November 7, 2009
Treatment interruption after pregnancy: effects on disease progression and laboratory findingsD H Watts, M Lu, B Thompson, et al.
Pediatrics|May 1, 1999
Combination therapy with stavudine (d4T) plus didanosine (ddI) in children with human immunodeficiency virus infection. The Pediatric AIDS Clinical Trials Group 327 TeamM W Kline, R B Van Dyke, J C Lindsey, et al.
Pediatrics|February 2, 1999
Planning for children whose parents are dying of HIV/AIDS. American Academy of Pediatrics. Committee on Pediatric AIDS, 1998-1999C Wilfert, J E Aronson, D T Beck, et al.
AIDS (London, England)|October 16, 2001
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)S H Eshleman, M Mracna, L A Guay, et al.
The Pediatric Infectious Disease Journal|July 6, 2000
Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study GroupJ S Read, K C Rich, J J Korelitz, et al.
AIDS (London, England)|March 1, 1996
Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmissionE M Rodriguez, L M Mofenson, B H Chang, et al.
The Journal of Infectious Diseases|August 1, 1997
Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. Women and Infants Transmission StudyR C Hershow, K A Riester, J Lew, et al.
The New England Journal of Medicine|August 5, 1999
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 TeamL M Mofenson, J S Lambert, E R Stiehm, et al.
The Journal of Infectious Diseases|June 2, 1998
Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission StudyD L Thomas, S A Villano, K A Riester, et al.
Pageof 5